Sjögren’s syndrome-associated microRNAs in CD14+ monocytes unveils targeted TGFβ signaling
Open Access
- 3 May 2016
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 18 (1) , 1-13
Abstract
Sjögren’s syndrome (SjS) monocytes have a pro-inflammatory phenotype, which may influence SjS pathogenesis. MicroRNAs (miRNAs) are small endogenously expressed molecules that can inhibit protein expression of their targeted genes and have important functions in regulating cell signaling responses. We profiled miRNAs in SjS monocytes to identify a SjS-specific miRNA profile and determine the potential roles of miRNAs in SjS pathogenesis. Total RNA was extracted from healthy control (HC, n = 10), SjS (n = 18), systemic lupus erythematosus (SLE, n = 10), and rheumatoid arthritis (RA, n = 10) peripheral blood CD14+ monocytes for miRNA microarray analysis. To validate select miRNAs from the microarray analysis, the original cohort and a new cohort of monocyte RNA samples from HC (n = 9), SjS (n = 12), SLE (n = 8), and RA (n = 9) patients were evaluated by quantitative reverse transcription (RT)-PCR. Functional predictions of differentially expressed miRNAs were determined through miRNA target prediction database analyses. Statistical analyses performed included one-way analysis of variance with Bonferroni post tests, linear regression, and receiver operating characteristic curve analyses. MiRNAs were predominantly upregulated in SjS monocytes in comparison with controls. Quantitative RT-PCR confirmations supported co-regulation of miR-34b-3p, miR-4701-5p, miR-609, miR-300, miR-3162-3p, and miR-877-3p in SjS monocytes (13/30, 43.3 %) in comparison with SLE (1/17, 5.8 %) and RA (1/18, 5.6 %). MiRNA-target pathway predictions identified SjS-associated miRNAs appear to preferentially target the canonical TGFβ signaling pathway as opposed to pro-inflammatory interleukin-12 and Toll-like receptor/NFkB pathways. Our results underscore a novel underlying molecular mechanism where SjS-associated miRNAs may collectively suppress TGFβ signaling as opposed to pro-inflammatory interleukin-12 and Toll-like receptor/NFκB pathways in SjS pathogenesis.Keywords
Funding Information
- National Institute of Dental and Craniofacial Research (DE019644, T90DE21990)
- National Institutes of Health (UL1 TR000064/TL1 TR000066)
This publication has 65 references indexed in Scilit:
- Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expressionAnnals of the Rheumatic Diseases, 2013
- TGFβ signaling plays a critical role in promoting alternative macrophage activationBMC Immunology, 2012
- Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjögren’s syndromeOral Diseases, 2011
- Gene Regulation by MAPK Substrate CompetitionDevelopmental Cell, 2011
- MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndromeArthritis & Rheumatism, 2011
- Increased IκBα expression is essential for the tolerogenic property of TGF‐β‐exposed APCSThe FASEB Journal, 2009
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- TGF-β signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2008
- The microRNA.org resource: targets and expressionNucleic Acids Research, 2007
- A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding HeteroduplexesCell, 2006